Copyright
©The Author(s) 2021.
World J Gastroenterol. Mar 14, 2021; 27(10): 976-989
Published online Mar 14, 2021. doi: 10.3748/wjg.v27.i10.976
Published online Mar 14, 2021. doi: 10.3748/wjg.v27.i10.976
Number of responses | Percentage (%) | ||
Specialty | Medical oncology | 15 | 53.6% |
Clinical oncology | 3 | 10.7% | |
Gastroenterology | 5 | 17.7% | |
Endocrinology | 3 | 10.7% | |
Surgery | 2 | 7.1% | |
Country of practice | Belgium | 2 | 7.1% |
Germany | 1 | 3.6% | |
France | 2 | 7.1% | |
Italy | 4 | 14.3% | |
Netherlands | 2 | 7.1% | |
Spain | 5 | 17.9% | |
Sweden | 2 | 7.1% | |
Switzerland | 2 | 7.1% | |
United Kingdom | 6 | 21.4% | |
Other | 2 | 7.1% | |
Practice at ENETS Centre of Excellence | Yes | 16 | 57.1% |
No | 12 | 42.9% | |
Use of guidelines to inform management of SBNETs | Yes | 28 | 100.0% |
No | 0 | 0.0% | |
Guidelines used | ENETS guidelines | 23 | 82.1% |
ESMO guidelines | 0 | 0.0% | |
NCCN guidelines | 0 | 0.0% | |
NANETS guidelines | 0 | 0.0% | |
Other | 5 | 17.7% |
- Citation: Lamarca A, Cives M, de Mestier L, Crona J, Spada F, Öberg K, Pavel M, Alonso-Gordoa T. Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment. World J Gastroenterol 2021; 27(10): 976-989
- URL: https://www.wjgnet.com/1007-9327/full/v27/i10/976.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i10.976